FDA Import Refusal 1FX-6724044-9/10001/1 — Revance Therapeutics, Inc
The FDA refused shipment 1FX-6724044-9/10001/1 from Revance Therapeutics, Inc (United States) on Jul 31, 2026. The refused product falls under Devices — IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE. Cited charges: 84,9999973,9999974,9999976 This firm has 3 other import refusals on record.
Refusal details
- Date
- Jul 31, 2026
- Country
- United States
- Product Category
- Devices
- Product Code
- 79LMH IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
- Charges
- 84,9999973,9999974,9999976